Biota management is doing as if only the US listing will save Biota in the future and trying to persuading Biota shareholders into believing that.
However, we shareholders know that the US listing is only the wonder drug for Biota's future, and the current Nabi merger proposal is not the only option to go to the US. Biota's share price, no matter in the US or in the Aus, is still dependent on the performance and prospect of Biota's pipelines and drugs. The timing and preparation of this proposed merger deal has turned out to be very poor and even disgusting.
We need a better management, which is the ultimate (more than a perfect) drug for Biota.
Just my thoughts.
Biota management is doing as if only the US listing will save...
Add to My Watchlist
What is My Watchlist?